Skip to main content
Premium Trial:

Request an Annual Quote

SomaLogic Raises $16.5M

NEW YORK (GenomeWeb) – In a notice filed on Friday with the US Securities and Exchange Commission, SomaLogic disclosed that it has raised $16.5 million.

According to the SEC document, the sale took place on Oct. 17 with equity going to two unidentified investors.

Last month, Novartis agreed to take an equity stake in SomaLogic as part of an extension of a multi-year agreement between the two companies. It is unclear if the recent financing relates to that agreement. SomaLogic declined to comment on the offering or identify the investors.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.